UFD1L anticorps (AA 1-277)
Aperçu rapide pour UFD1L anticorps (AA 1-277) (ABIN1885878)
Antigène
Voir toutes UFD1L AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-277
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 277 of UFD1L
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.500
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- UFD1L (Ubiquitin Fusion Degradation Protein 1 Homolog (UFD1L))
-
Autre désignation
- UFD1L
-
Sujet
-
The protein encoded by this gene forms a complex with two other proteins, NPL4 and VCP, that is necessary for the degradation of ubiquitinated proteins.In addition, this complex controls the disassembly of the mitotic spindle and the formation of a closed nuclear envelope after mitosis.Mutations in this gene have been associated with Catch 22 syndrome as well as cardiac and craniofacial defects.Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq]
-
Poids moléculaire
- 35 kDa
-
ID gène
- 7353
-
NCBI Accession
- NP_005650, NM_005659
Antigène
-